We have to remember the market cap hit over $300m last year purely on the basis of CEO change, possibly with the thought of a more speedy, more definitive path forward. I think the technical path forward is clear, the commercial not so, but it does hinge on the technical outcomes.
in saying that the decision to go depression vs Fragile. X was a commercial one, that could be a bigger market than the aspects of AD we are targeting.
This stock could go anywhere, another rise to $300m or even an IMU market cap.
Its all speculative until we get big pharma interest.
We have to remember the market cap hit over $300m last year...
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.001(3.57%) |
Mkt cap ! $68.22M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.6¢ | $56.27K | 2.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 971292 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 152383 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.6¢ |
Change
-0.001 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.6¢ | 1276146 | ||
| Last updated 15.56pm 24/05/2024 ? | |||||
| ACW (ASX) Chart |